Lv2
170 积分 2023-09-30 加入
Characteristics of Ocular Inflammatory Side Effects Associated with Immune Checkpoint Inhibitors in a Northern California Population
1天前
已完结
Development of Vogt–Koyanagi–Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report
1天前
已完结
Vogt‐Koyanagi‐Harada (VKH) like syndrome in a patient treated with pembrolizumab for metastatic colorectal cancer
2天前
求助中
Ocular Immune-Related Adverse Events Associated with PD-1 Inhibitors: From Molecular Mechanisms to Clinical Management
2天前
已完结
Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database
7天前
已完结
Immunotherapy and Direct Acting Anti-Cancer Agent Associated-Uveitis
7天前
已完结
Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes
9天前
已完结
Immunotherapy and Direct Acting Anti-Cancer Agent Associated-Uveitis
9天前
已完结
Sunset Glow Fundus and Bilateral Choroidal Neovascularization in a Pediatric Patient Receiving Nivolumab: A Rare Pediatric Immune-Related Ocular Complication
10天前
已完结
Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database
10天前
已关闭
皖公网安备34019202002308
